787590-51-6

Basic information

• Product Name: Imidazo[1,2-a]pyrazin-8-amine, 3-bromo-N-(4-methoxyphenyl)-
• CAS NO: 787590-51-6
• Molecular Formula: C13H11BrN4O
• Molecular Weight: 319.161
• Mol File: 787590-51-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Imidazo[1,2-a]pyrazin-8-amine, 3-bromo-N-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyrazin-8-amine, 3-bromo-N-(4-methoxyphenyl)-(787590-51-6)
• EPA Substance Registry System: Imidazo[1,2-a]pyrazin-8-amine, 3-bromo-N-(4-methoxyphenyl)-(787590-51-6)

Safety Data

• Hazardous Substances Data: 787590-51-6(Hazardous Substances Data)

Upstream product

• 855719-15-2 trifluoroethanol 
• 104-94-9 4-methoxy-aniline 
• 63744-21-8 3,5-dibromoimidazo<1,2-a>pyrazine 
• 936361-36-3 3,8-dibromo-imidazo[1,2-a]pyrazine 

Downstream Products

• 1011471-99-0 3-(8-(4-methoxyphenylamino)imidazo[1,2-a]pyrazin-3-yl)benzamide 

Relevant articles and documents

COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Compounds of formula (I): wherein R1, R2, X1, and X2 are as defined herein, are useful for the treatment or prophylaxis of conditions such as Duchenne muscular dystrophy, Becker muscular dystrophy, and cachexia.

Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors

The present invention relates to 8-amino-aryl-substituted imidazopyrazines which modulate the activity of protein kinases (“PKs”). The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.